Abstracting and Coding Guide for the Hematopoietic Diseases. Including ICD-O-3 Codes M-9731/3 to M-9764/3, M-99-20/3 to M-9989/3

摘要

On Januay 1, 2001, cancer registrars in the United States began coding primary site and morphology terms using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Over 200 new terms and synonyms were added in the third edition in the narrow range of codes from M-9590 to M-9989. This Abstracting and Coding Guide for the Hematopoietic Diseases was prepared in response to many questions about whether a variety of blood diseases are reportable to cancer registries. One of the issues with the case reportability changes implemented with ICD-O-3 is that registrars are largely unfamiliar with many of these blood and bone marrow diseases and all the different names for individual diseases. Although this book does not include all of the lymphatic and hematopoietic diseases, it covers the majority of diseases that meet any of the following criteria: (1) New terms or codes in ICD-O-3; (2) Rare or unusual blood or bone marrow diseases; (3) Confusing terminology or many different names for the same condition; (4) Coded in ICD-9 CM in non-specific 'other' codes along with other non-reportable conditions; and (5) Generally have no TNM staging scheme.